South Carolina Zantac Lawsuit Attorneys

Ranitidine is a drug used to treat and prevent stomach ulcers and other conditions associated with the overproduction of stomach acid. Zantac is one popular ranitidine medication available by prescription and over the counter. Zantac is widely recommended by medical professionals and used regularly by many. Although formerly believed to be safe, it has been found that regular use of ranitidine medications like Zantac could possibly be linked to certain forms of cancer.

In light of this information, the U.S. Food and Drug Administration (FDA) recommended that all ranitidine medications be taken off the market. If you or a loved one believe that a cancer diagnosis is related to regular use of Zantac, you may be able to take legal action. Contact an attorney at the Steinberg Law Firm to discuss the specifics of your case and see if you are entitled to compensation.

Zantac and Cancer

Zantac and other ranitidine medications contain small amounts of the carcinogen N-nitrosodimethylamine (NDMA.) The level of risk to Zantac users is currently under investigation however, NDMA is a known environmental contaminant and a probable human carcinogen. It may cause liver damage, internal bleeding and increases the risk of death in individuals who are exposed to it. It is found in water supplies and foods like cured meats, dairy products and vegetables.

A class action lawsuit filed in California alleges that the makers of Zantac were aware of the scientific evidence showing a link between NDMA and cancer and failed to properly warn users of the drug of the danger. The lawsuit claims that one pill of Zantac contains much more NDMA than the maximum acceptable daily amount that is safe to consume, which is 100 nanograms.

Levels on NDMA in ranitidine are considered low, but the FDA is studying the effect of regular, increased exposure. Other drugs used to treat high blood pressure and heart conditions that also contain NDMA were already recommended for recall by the FDA.